Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
AXSM - TOTAL CURRENT ASSETS
Total Current Assets AXSM - Axsome Therapeutics, Inc.
485 M
LAST VALUE
40.52%
2 YEAR CAGR
17.09%
5 YEAR CAGR
67.78%
10 YEAR CAGR